A review paper by Raymond Chang, published on Papers with Code, proposing lactoferrin as a potential intervention for COVID-19. The paper examines the glycoprotein's established in vitro antiviral efficacy against related coronaviruses and its immunomodulatory effects. It argues for further research into lactoferrin's role as a preventative and adjunct treatment.
Use Cases
- Literature review on lactoferrin's antiviral mechanisms based on the paper's discussion.
- Analysis of potential nutritional supplement interventions for COVID-19 based on the paper's proposal.
- Research into immunomodulatory treatments for severe COVID-19 cases based on the described pathophysiology.
Strengths
- The paper is published under an Open Access (green) license, facilitating free access.
- It reviews established in vitro antiviral efficacy of lactoferrin against a wide range of viruses.
Limitations
- Description metadata is limited; actual data quality requires manual inspection after download.
- Column-level documentation is absent; field semantics must be inferred after download.
- Row count is unknown, which may limit suitability assessment.
Provenance
- Source
- Raymond Chang via Papers with Code.
- Collection Method
- Likely a literature review and synthesis of existing research.